Stock markets have been experiencing significant volatility of late. This is largely because of the ongoing trade war, which has also led to expectations of economic slowdown and rising inflation. As such, the Federal Reserve has kept interest rates steady. In such an uncertain environment, retail investors face significant challenges in selecting the right stocks and achieving strong returns.One way to cut short this task is to follow brokers’ recommendations. In this regard, stocks like Urban Outfitters, ...

Needham analyst Mike Matson upgraded Inogen, Inc INGN from Hold to Buy, with a price forecast of $12.On May 7, the company reported its first-quarter results.Total revenue in the quarter was $82.3 million, an increase of 5.5% from the prior-year period, or 7.1% at constant currency rates, due to higher demand from international and domestic business-to-business customers.Matson highlighted the turnaround efforts led by the company’s new management team, which remains underappreciated by the market.Also Read ...

Investors might want to bet on Inogen (INGN) , as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.The sole determinant of the Zacks rating is a company's changing earnings picture. The Zacks Consensus Estimate -- the consensus of EPS estimates from the sell-side analysts covering the stock -- for the current and following years is tracked by the system.Since a c ...

Inogen (INGN) has been on a downward spiral lately with significant selling pressure. After declining 15.7% over the past four weeks, the stock looks well positioned for a trend reversal as it is now in oversold territory and there is strong agreement among Wall Street analysts that the company will report better earnings than they predicted earlier.How to Determine if a Stock is OversoldWe use Relative Strength Index (RSI), one of the most commonly used technical indicators, for spotting whether a stock is ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period From to Commission file number: 001-36309 INOGEN, INC. (Exact name of registrant as specified in its charter) Delaware 33-0989359 (State or other jurisdiction of i ...

Inogen, Inc. (INGN) incurred an adjusted loss per share of 11 cents for first-quarter 2025, which was narrower than the adjusted loss per share of 45 cents in the year-ago period and the Zacks Consensus Estimate of a loss of 52 cents per share. (Find the latest EPS estimates and surprises on Zacks Earnings Calendar.)GAAP loss per share for the quarter was 25 cents, narrower than the year-earlier loss of 62 cents.INGN’s Revenues in DetailInogen registered revenues of $82.3 million for the first quarter, up 5 ...

The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call. Inogen shares have lost about 22.9% since the beginning of the year versus the S&P 500's decline of -4.7%. What's Next for Inogen? Inogen (INGN) came out with a quarterly loss of $0.25 per share versus the Zacks Consensus Estimate of a loss of $0.52. This compares to loss of $0.62 per share a year ago. These fig ...

Inogen (INGN) Q1 2025 Earnings Call May 07, 2025 05:00 PM ET Company Participants None - ExecutiveRyan Peterson - Associate Director of Investor RelationsKevin Smith - CEO, President & DirectorMichael Bourque - Executive VP, CFO & TreasurerColin Clark - Associate VP - Healthcare Equity Research Conference Call Participants None - AnalystMike Matson - Senior Equity Research AnalystMargaret Kaczor Andrew - Research Analyst - Healthcare None Welcome to Inogen's First Quarter twenty twenty five Earnings Confere ...

May 7, 2025 Q1 2025 Supplemental Financial Information Use of Non-GAAP Financial Measures Inogen has presented certain financial information in accordance with U.S. GAAP and also on a non-GAAP basis for the three months ended March 31, 2025, and March 31, 2024. Management believes that non-GAAP financial measures, taken in conjunction with U.S. GAAP financial measures, provide useful information for both management and investors by excluding certain non-cash and other expenses that are not indicative of Ino ...

Exhibit 99.1 Inogen Announces First Quarter 2025 Financial Results GOLETA, Calif., May 7, 2025 -- Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced financial results for the quarter ended March 31, 2025. "Inogen's strong first quarter financial results underscore our success in driving improved commercial and operational execution," said Kevin Smith, President and Chief Executive Officer. "We are making great p ...